Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Leukemia derived dendritic cells (LDCs) are functionally deficient and inferior to DC leukemia fusion cells as a tumor vaccine for AML

Leukemia derived dendritic cells (LDCs) are functionally deficient and inferior to DC leukemia fusion cells as a tumor vaccine for AML. Blood. 2005; 106(11):782a.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.